Adverse effects: drowsiness, hypersomnia, and excessive sleepiness · otherwise healthy adults and children with common cold symptoms
Antihistamine‐analgesic showed no clear difference in adverse effects: drowsiness, hypersomnia, and excessive sleepiness compared with placebo (low certainty).
1 finding from 1 review
Adverse effect: fatigue · people (aged 10–64 years) with drug‐resistant focal epilepsy
Vigabatrin may leads to higher adverse effects: fatigue Duration of treatment (range): 8–36 weeks compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: general adverse events (UKU Average change score) · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Intervention not reported
Adverse effects experienced by mother and/or fetus or nursing baby · women with a history of postnatal depression
1 finding from 1 review
Intervention not reported
Adverse effects ‐ Body dissatisfaction (Child Picture Scale 1 ‐ 7) · Adults or children with overweight or obesity
1 finding from 1 review
Adverse effects: IOP spikes · adults undergoing transabdominal robotic assisted laparoscopic surgery
1 finding from 1 review
Number of participants reporting an adverse event · people with venous leg ulcers
It is very uncertain whether alginate dressing changes proportion of participants experiencing adverse effects at 6 weeks compared with hydrocolloid dressing (very low certainty).
1 finding from 1 review
Adverse effects: 3. Metabolic weight gain ≥7% of total body weight · schizophrenia
QUETIAPINE showed no clear difference in adverse effects: 3. Metabolic weight gain ≥7% of total body weight compared with PALIPERIDONE (moderate certainty).
1 finding from 1 review
Adverse effects: 3. Metabolic weight gain ≥7% of total body weight · schizophrenia
QUETIAPINE showed no clear difference in adverse effects: 3. Metabolic weight gain ≥7% of total body weight compared with RISPERIDONE (moderate certainty).
1 finding from 1 review
Adverse effects: 3. Metabolic weight gain ≥7% of total body weight · schizophrenia
QUETIAPINE probably leads to higher adverse effects: 3. Metabolic weight gain ≥7% of total body weight compared with ZIPRASIDONE (moderate certainty).
1 finding from 1 review
Adverse effects ‐ important extrapyramidal adverse effects · patients with psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effect: fatigue · people with drug‐resistant focal epilepsy
Gabapentin may leads to higher adverse effects: fatigueNumber of participants experiencing fatigue compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: headache · people with drug‐resistant focal epilepsy
Levetiracetam showed no clear difference in adverse effects: 5 most common adverse effects (any age) – headache compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects experienced by mother and/or foetus or nursing baby · women with a history of postnatal depression
1 finding from 1 review
Adverse effects during antidepressant treatment period (0‐12 weeks) · adults living with HIV and depression
It is very uncertain whether selective serotonin reuptake inhibitors (SSRI) changes adverse effects during antidepressant treatment period (0‐12 weeks) compared with tricyclic antidepressant (TCA) (very low certainty).
1 finding from 1 review
Adverse effects during antidepressant treatment period (0‐12 weeks) · adults living with HIV and depression
It is very uncertain whether antidepressant changes adverse effects during antidepressant treatment period (0‐12 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: pain following injection · Participants of any age and gender undergoing dental procedures, and volunteers who took part in simulated scenario studies in which…
4% articaine, 1:100,000 epinephrine probably leads to higher adverse effects: pain following injection, Heft-Parker VAS 0-170 mm compared with 2% lidocaine, 1:100,000 epinephrine (moderate certainty).
1 finding from 1 review
Adverse drug effects · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in adverse effects ‐ general ‐ one or more drug‐related adverse effect compared with BENZODIAZEPINE: c. MIDAZOLAM (low certainty).
1 finding from 1 review
Serious adverse events Analysis 11.2 · children with acute encephalitis
It is very uncertain whether intravenous immunoglobulin with or without standard care changes ≥ 1 serious adverse event RR (M‐H, random‐effects analysis, 95% CI) compared with standard care alone or placebo (very low certainty).
1 finding from 1 review
Investigator‐assessed severe adverse effects Blistering or scarring · Mild, moderate and severe acne vulgaris
1 finding from 1 review